These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 9328113)

  • 1. CD28 costimulation and T lymphocyte proliferative responses in HIV-1 infection.
    Carlesimo M; Pontesilli O; Varani AR; Bernardi ML; Mazzone AM; Rosso R; Guerra EC; Cassone A; Paganelli R; Aiuti F
    Clin Exp Immunol; 1997 Sep; 109(3):406-11. PubMed ID: 9328113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiviral effect and ex vivo CD4+ T cell proliferation in HIV-positive patients as a result of CD28 costimulation.
    Levine BL; Mosca JD; Riley JL; Carroll RG; Vahey MT; Jagodzinski LL; Wagner KF; Mayers DL; Burke DS; Weislow OS; St Louis DC; June CH
    Science; 1996 Jun; 272(5270):1939-43. PubMed ID: 8658167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of T-cell response to CD3 plus CD28 monoclonal antibodies in HIV-1 infected subjects treated with highly active antiretroviral therapy.
    Carlesimo M; Bernardi ML; Mattiacci G; Pierdominici M; Ferrara R; Donnanno S; Alario C; Aiuti F
    J Biol Regul Homeost Agents; 2000; 14(1):38-40. PubMed ID: 10763891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The mode and duration of anti-CD28 costimulation determine resistance to infection by macrophage-tropic strains of human immunodeficiency virus type 1 in vitro.
    Creson JR; Lin AA; Li Q; Broad DF; Roberts MR; Anderson SJ
    J Virol; 1999 Nov; 73(11):9337-47. PubMed ID: 10516042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for intact costimulation via CD28 and CD27 molecules in hyporesponsive T cells from human immunodeficiency virus-infected individuals.
    Meyaard L; Kuiper H; Otto SA; Wolthers KC; van Lier RA; Miedema F
    Eur J Immunol; 1995 Jan; 25(1):232-7. PubMed ID: 7531146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD28 costimulation and CD28 expression in T lymphocyte subsets in HIV-1 infection with and without progression to AIDS.
    Choremi-Papadopoulou H; Panagiotou N; Samouilidou E; Kontopidou F; Viglis V; Antoniadou A; Kosmidis J; Kordossis T
    Clin Exp Immunol; 2000 Mar; 119(3):499-506. PubMed ID: 10691923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune hyperactivation of HIV-1-infected T cells mediated by Tat and the CD28 pathway.
    Ott M; Emiliani S; Van Lint C; Herbein G; Lovett J; Chirmule N; McCloskey T; Pahwa S; Verdin E
    Science; 1997 Mar; 275(5305):1481-5. PubMed ID: 9045614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased cytolytic T lymphocyte activity and decreased B7 responsiveness are associated with CD28 down-regulation on CD8+ T cells from HIV-infected subjects.
    Vingerhoets JH; Vanham GL; Kestens LL; Penne GG; Colebunders RL; Vandenbruaene MJ; Goeman J; Gigase PL; De Boer M; Ceuppens JL
    Clin Exp Immunol; 1995 Jun; 100(3):425-33. PubMed ID: 7539725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphocyte activation in HIV-1 infection. II. Functional defects of CD28- T cells.
    Borthwick NJ; Bofill M; Gombert WM; Akbar AN; Medina E; Sagawa K; Lipman MC; Johnson MA; Janossy G
    AIDS; 1994 Apr; 8(4):431-41. PubMed ID: 8011246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low T-cell responses to CD3 plus CD28 monoclonal antibodies are predictive of development of AIDS.
    Roos MT; Prins M; Koot M; de Wolf F; Bakker M; Coutinho RA; Miedema F; Schellekens PT
    AIDS; 1998 Oct; 12(14):1745-51. PubMed ID: 9792374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term evaluation of cellular immunity during antiretroviral therapy and immunization with human immunodeficiency virus type 1 (HIV-1) Env glycoprotein in HIV-1-infected persons.
    Carlesimo M; Pontesilli O; Guerra EC; Varani AR; Bernardi ML; Ricci G; Alario C; Pirillo MF; Mattiacci G; Leone P; Cassone A; Aiuti F
    J Infect Dis; 1997 Oct; 176(4):904-12. PubMed ID: 9333148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD28 costimulation induces delta opioid receptor expression during anti-CD3 activation of T cells.
    Nguyen K; Miller BC
    J Immunol; 2002 May; 168(9):4440-5. PubMed ID: 11970987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T cell responses to recall antigens, alloantigen, and mitogen of HIV-infected patients receiving long-term combined antiretroviral therapy.
    Blazevic V; Sahgal N; Kessler HA; Landay AL; Shearer GM
    AIDS Res Hum Retroviruses; 2000 Nov; 16(17):1887-93. PubMed ID: 11118074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intrinsic resistance to T cell infection with HIV type 1 induced by CD28 costimulation.
    Riley JL; Carroll RG; Levine BL; Bernstein W; St Louis DC; Weislow OS; June CH
    J Immunol; 1997 Jun; 158(11):5545-53. PubMed ID: 9164979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A recombinant anti-carcinoembryonic antigen immunoreceptor with combined CD3zeta-CD28 signalling targets T cells from colorectal cancer patients against their tumour cells.
    Hombach A; Schlimper C; Sievers E; Frank S; Schild HH; Sauerbruch T; Schmidt-Wolf IG; Abken H
    Gut; 2006 Aug; 55(8):1156-64. PubMed ID: 16188919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous cross-linking of CD6 and CD28 induces cell proliferation in resting T cells.
    Osorio LM; Rottenberg M; Jondal M; Chow SC
    Immunology; 1998 Mar; 93(3):358-65. PubMed ID: 9640246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential regulation of HIV-1 fusion cofactor expression by CD28 costimulation of CD4+ T cells.
    Carroll RG; Riley JL; Levine BL; Feng Y; Kaushal S; Ritchey DW; Bernstein W; Weislow OS; Brown CR; Berger EA; June CH; St Louis DC
    Science; 1997 Apr; 276(5310):273-6. PubMed ID: 9092480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expansion of restricted cellular immune responses to HIV-1 envelope by vaccination: IL-7 and IL-12 differentially augment cellular proliferative responses to HIV-1.
    Kim JH; Loveland JE; Sitz KV; Ratto Kim S; Mclinden RJ; Tencer K; Davis K; Burke DS; Boswell RN; Redfield RR; Birx DL
    Clin Exp Immunol; 1997 May; 108(2):243-50. PubMed ID: 9158092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential production of IL-10 by T cells and monocytes of HIV-infected individuals: association of IL-10 production with CD28-mediated immune responsiveness.
    Kumar A; Angel JB; Daftarian MP; Parato K; Cameron WD; Filion L; Diaz-Mitoma F
    Clin Exp Immunol; 1998 Oct; 114(1):78-86. PubMed ID: 9764607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimization of human T-cell expansion ex vivo using magnetic beads conjugated with anti-CD3 and Anti-CD28 antibodies.
    Kalamasz D; Long SA; Taniguchi R; Buckner JH; Berenson RJ; Bonyhadi M
    J Immunother; 2004; 27(5):405-18. PubMed ID: 15314550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.